Free Trial
NYSEARCA:REVS

Columbia Research Enhanced Value ETF (REVS) Price, Holdings, & News

$25.94 +0.28 (+1.09%)
As of 01/21/2025 04:10 PM Eastern

About Columbia Research Enhanced Value ETF (NYSEARCA:REVS)

Key Stats

Today's Range
$25.78
$25.96
50-Day Range
$24.49
$26.99
52-Week Range
$21.50
$27.03
Volume
20,083 shs
Average Volume
7,174 shs
Market Capitalization
$46.69 million
Assets Under Management
$63.20 million
Dividend Yield
1.85%
Net Expense Ratio
0.19%
Aggregate Rating
Moderate Buy

ETF Overview

The Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is managed by Columbia.

Columbia Research Enhanced Value ETF Expenses

TypeREVSLarge Cap ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.19%0.58%0.55%0.51%0.52%
Other Expenses0.00%0.31%0.49%0.57%0.54%
Total Expense0.19%0.65%0.71%0.73%0.71%
Fee Waiver0.00%-0.26%-0.51%-0.66%-0.56%
Net Expense0.19%0.62%0.61%0.58%0.59%
Receive REVS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Columbia Research Enhanced Value ETF and its competitors with MarketBeat's FREE daily newsletter.

REVS ETF News Headlines

Columbia Research Enhanced Real Estate ETF
REVS Columbia Research Enhanced Value ETF
Did You See Trump’s Manhattan Project Bombshell?
This secret document contains stunning details about Donald Trump’s very first order of business… the minute he steps back into the White House. Because if what’s in this leaked document is even half true (and trust me, it comes from a very, very credible source)... Trump’s first Executive Order would easily be the boldest, most mind-blowing and daring American initiative ANY U.S. President has launched in over 80 years.
Columbia Thermostat A CTFAX
See More Headlines

REVS ETF - Frequently Asked Questions

Columbia Research Enhanced Value ETF's stock was trading at $24.73 at the beginning of 2025. Since then, REVS stock has increased by 4.9% and is now trading at $25.94.
View the best growth stocks for 2025 here
.

Shares of REVS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Columbia Research Enhanced Value ETF investors own include The GEO Group (GEO), Global X SuperDividend REIT ETF (SRET), BlackRock Capital Investment (BKCC), British American Tobacco (BTI), Energy Transfer (ET), International Business Machines (IBM) and Annaly Capital Management (NLY).

Fund Details

Issuer
Columbia
Fund Name
Columbia Research Enhanced Value ETF
Tax Classification
Regulated Investment Company
Current Symbol
NYSEARCA:REVS
Inception Date
9/25/2019
Fund Manager
Christopher Lo, Jason Wang
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
Beta Advantage Research Enhanced U.S. Value Index
Category
Size and Style
Focus
Large Cap
Development Level
Developed Markets
Region
North America
Number of Holdings
319

Fund Statistics

Assets Under Management
$63.20 million
Average Daily Volume
$0.00
Discount/Premium
0.00%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
Columbia Management Investment Advisers, LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
ALPS Distributors, Inc.
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Jane Street

Options

Optionable
N/A
Short Interest
7,800 shs

Miscellaneous

Beta
0.76
Creation Unit
50,000
Creation Fee
$500.00
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report

Top 10 REVS Holdings

REVS Sector Exposure

REVS Industry Exposure


This page (NYSEARCA:REVS) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners